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Abstract: Herbal medicines have become strongly preferred treatment to reduce the negative impacts of diabetes 
mellitus (DM) and its severe complications due to lesser side effects and low cost. Recently, strong anti-hyperglycemic 
effect of Euphorbia thymifolia Linn. (E. thymifolia) on mice models has reported but the action mechanism of its 
bioactive compounds has remained unknown. This study aimed to evaluate molecular interactions existing between 
various bioactive compounds in E. thymifolia and targeted proteins related to Type 2 DM. This process involved the 
molecular docking of 3D structures of those substances into 4 targeted proteins: 11-β hydroxysteroid dehydrogenase 
type 1, glutamine: fructose-6-phosphate amidotransferase, protein-tyrosine phosphatase 1B and mono-ADP-ribo-
syltransferase sirtuin-6. In the next step, LigandScout was applied to evaluate the bonds formed between 20 ligands 
and the binding sites of each targeted proteins. The results identified seven bioactive compounds with high binding 
affinity (<−8.0 kcal/mol) to all 4 targeted proteins including β-amyrine, taraxerol, 1-O-galloyl-β-d-glucose, corilagin, 
cosmosiin, quercetin-3-galactoside and quercitrin. The pharmacophore features were also explained in 2D figures 
which indicated hydrophobic interactions, hydrogen bond acceptors and hydrogen bond donors forming between 
carbonyl oxygen molecules of those ligands and active site residues of 4 targeted protein.
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Background
Euphorbia thymifolia is a small prostrate herbaceous 
annual weed which is abundant in waste places and open 
grasslands and distributes in most Asian countries. This 
medicinal plant has been studied for many bioactivi-
ties and therapeutic effects such as anti-microbial effect 
(Killedar et al. 2011), bronchial asthma (Sharma and Tri-
pathi 1984) and the anti-hyperglycemic effect of Euphor-
biaceae family has been fully reviewed (Bnouham et  al. 
2006). Besides that, E. thymifolia has also been tradi-
tionally used for treatment of gastrointestinal disorder, 
inflammatory and respiratory diseases (Loi 2015).
Diabetes mellitus (DM) and its complications are main 
causes of deaths in most countries. Type 2 DM has also 
been known as another terms “Non-insulin dependent 
diabetes mellitus (NIDDM)” which accounted for more 
than 90 % of diagnosed cases of DM in adults (Interna-
tional Diabetes Federation (IDF) 2015). In accordance 
with Ford et al. (2002), the statistics of patients suffering 
Type 2 DM and metabolic syndromes were estimated 
about 50 million in the US and 314 million around the 
world and this number was predicted to increase dra-
matically in the next decades. The feature of Type 2 DM 
is the partial or complete failure in using insulin (insulin 
resistance) even though the functional insulin is available 
and then causes hyperglycemia. To overcome this resist-
ance, the pancreatic β cells produce extra mount of insu-
lin to maintain glucose in the normal range. However, 
this process is only effective in the short term as burnout 
β cell occurs. At this time, the patients have suffered Type 
2 DM.
Many efforts to figure out the effective treatments for 
Type 2 DM have been increased. For many years, scien-
tists have endeavored to apply not only pharmacological 
methods but also non-pharmacological approaches but 
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none of them met all safety requirements in medication. 
Losing weight and doing exercise have been highly rec-
ommended as two major non-drug therapies to increase 
insulin sensitivity. In aspect of pharmaceutical science, 
although metformin and thiazolidinedione both have 
good effect in insulin resistance, they cannot be widely 
used because of their undesirable side effects. Currently, 
research on relationships between antioxidant com-
pounds and Type 2 DM has been well published and doc-
umented. People revealed that an intake of antioxidant in 
diet has contributed to reduce the development of Type 
2 DM (Montonen, et  al. 2004; Evans 2007). Besides, in 
2005, Fraga investigated that the intake of dark chocolate 
which was a rich source of flavonols could decrease blood 
pressure and improved insulin sensitivity in healthy per-
sons (Fraga 2005).
In the light of these evidences, the objective of this 
research is to test the anti-hyperglycemic activity of anti-
oxidant compounds in the ethanolic extracts of E. thymi-
folia by using them as ligands for four targeted proteins to 
determine which compound is effective binder. The chem-
ical composition analyzed by GC–MS from areal part of 
E. thymifolia suggested three main families: tannin, fla-
vonoid and terpenoid (Sandeep et  al. 2009; Prasad and 
Bisht 2011) which are strong anti-oxidant compounds. 
Possessing polyphenol structure involving high number 
of hydroxyl group inside, tannin and flavonoid were, thus, 
predicted to be able to form hydrogen bonds with various 
reactive oxygen species, such as singlet oxygen, peroxyni-
trite and hydrogen peroxide which are major causes of cell 
damages. Due to this mechanism, tannin and flavonoid 
were considered to play potential roles in reducing the 
oxidative stress related to Type 2 DM (Evans 2007; Maiese 
et  al. 2007). Terpenoid is an enormous class of organic 
compound in plant whose potential antioxidant activity 
has already studied (Gonzalez-Burgos and Gomez-Ser-
ranillos 2012). However, there are no research indicating 
their affinity for Type 2 DM. Four targeted proteins used 
in this study was previously investigated to serve as poten-
tial drug target for Type 2 DM (Nguyen and Le 2012; Shi 
2009; Vogel 2002). 11β-HSD1 (11β-hydroxysteroid dehy-
drogenase type I) or “cortisone reductase” is an NADPH-
dependent enzyme highly expressed in main metabolic 
tissues including liver, adipose tissue, and the central 
nervous system. In these tissues, HSD11B1 reduces cor-
tisone to the active hormone cortisol that activates glu-
cocorticoid receptors. 11βHSD1 inhibition is a tempting 
target for the treatment of glucortinoid-associated dis-
eases, especially of Type 2 DM (Davani, et  al. 2004; 
Andrews and Walker 1999). Glutamine-fructose-6-phos-
phate amidotransferase (GFAT or GFPT) is the first and 
rate-limiting enzyme of the hexosamine pathway. GFAT 
controls the flux of glucose into the hexosamine pathway 
and catalyzes the formation of glucosamine 6-phosphate. 
The majority of glucose will enter the glycolysis pathway, 
with a small percentage entering the hexosamine pathway. 
GFPT or GFAT regulate the hexosamine pathway prod-
ucts. Therefore, this enzyme involved in a therapeutic 
target against Type 2 DM (Chou 2004). Protein-tyrosine 
phosphatase 1B (PTP1B) is a negative regulator of the 
insulin signaling pathway and is considered a promising 
potential therapeutic target, in particular for treatment 
of Type 2 DM. It has also been implicated in the develop-
ment of breast cancer and has been explored as a poten-
tial therapeutic target in that avenue as well. Sirtuin-6 or 
Mono-ADP ribosyltransferase-sirtuin-6 (SIRT6) is a stress 
responsive protein deacetylase and mono-ADP ribosyl-
transferase enzyme encoded by the SIRT6 gene. SIRT6 
functions in multiple molecular pathways related to aging, 
including DNA repair, telomere maintenance, glycolysis 
and inflammation. Promisingly, the absence of enzyme 
SIRT6 may lead to dramatically induced of blood sugar 
level (Hasan et al. 2002). The objective of this study was 
to display a range of bioactive compounds from all three 
families and determine if and how they interact with pro-
teins that is important to Type 2 DM (Muthumani et al. 




3D structure of 11-β HSD1, GFAT, PTP1B, SIRT6 were 
taken from Protein Data Bank as following 11β-HSD1 
(PDB code 1XU7), GFAT (PDB code 2ZJ3), PTP1B 
(PDB code 4Y14) and SIRT6 (PDB code 3K35). To ver-
ify the capacity of the model in reproducing experimen-
tal observation with new ligand, all these structures 
were tested again at the binding site. Following this 
way, 11β-HSD1 (PDB code 1XU7) was tested again with 
molecule: NADPH dihydro-nicotinamide-adenine-
dinucleotide phosphate (NDP), GFAT (PDB code 2ZJ4) 
was tested with 2-deoxy-2-amino glucitol-6-phosphate 
(AGP), SIRT6 (PDB code 3K35) with adenosine-5-di-
phosphoribose (APR) and PTP1B (PDB code 4Y14) with 
3-bromo-4-[difluoro(phosphono)methyl]-N-methyl-Nal-
pha-(methylsulfonyl)-l-phenylalaninamide. This work 
was done by Autodock Vina (Trott and Olson 2009) and 
VMD was used for visualization (Humphrey et al. 1996).
Bioactive compound preparation
Most of the 3D structures of drug molecules in 
E.thymifolia were downloaded from PubChem 
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Compound section of National Center for Biotechnology 
Information (NCBI) and the others were drawn by Gauss-
View 5 (Dennington et  al. 2009). Ligands during this 
process also being checked for Torsion count to detect 
currently active bonds with default settings. Importantly, 
amide bonds were checked and treated as non-rotatable. 
Ligands were also utilized to merge non-polar hydrogens. 
The 2D structures of 20 ligands are illustrated in Table 1.
Docking simulations
Autodock Vina (Trott and Olson 2009) was employed for 
binding affinity measurement. The content of configure 
file was determined as position of receptor file, ligand 
file, data of Grid-box’s three coordinates X, Y, Z were 
18.125, −27.72, −0.34 respectively in case of 11β-HSD1, 
8.82, 5.31, −7.903 for GFAT, −11.21, −22.77, −6.75 in 
PTP1B, 14.5, −18.02 and 17.04 in SIRT6, the size of Grid 
box which was set up in 30 × 30 × 30 points, number of 
modes which were 10 and the energy range which was set 
up at 9 kcal/mol. Docking process in AutoDock Vina has 
been performed with 1000 of exhaustiveness for enhanc-
ing accuracy.
Pharmacophore analysis
This part of process was carried out by using the phar-
macophore tool included in LigandScout (Wolber and 
Langer 2005). The program showed us the 2D and 3D 
structure with the position and interaction of ligand in 
the binding pocket of the receptor. From these 2D fig-
ures, some types of bond were identified by color and 
symbol. Four features namely hydrogen bond acceptor 
(HBA), hydrogen bond donor (HBD), negative ionizable 
area (NIA), hydrophobic interaction were labeled as red 
arrow, green arrow, red star and orange bubble (support-
ing information) respectively.
Results and discussion
Free energy binding of bioactive compound to targeted 
proteins
The line chart (Fig.  1) showed the binding capacity of 
all three family bioactive compounds: tannin, flavonoid 
and terpenoid in E. thymifolia on 4 proteins related to 
Type 2 DM in humans. In this chart, tannin and flavo-
noid families included first seven compounds. Among 
those docking result, the absolute value of binding energy 
ranged from 7.2 to 10.4 (kcal/mol; Fig. 1). In this range, 
the greatest result was in five compounds of both families 
which were higher 8 kcal/mol in term of absolute value. 
Those are cosmosiin, quercetin-3-galactoside, querci-
trin, corilagin, 1-O-galloyl-β-d-glucose and which were 
selected for pharmacophore analysis step. Besides that, 
kaempferol and quercetin of flavonoid family also had 
good results but this was different in each protein, per-
haps the amino acid construction of each protein. For 
example, the binding affinity of quercetin was 9.7 and 
8.3  kcal/mol in 11β HSD1 (1XU7) and SIRT6 (3K35) 
respectively, compared to 7.8 and 7.6 in PTP1B (4Y14) 
and GFAT1 (2ZJ3). Although there have been fluctua-
tions in this range, the result of tannin and flavonoid 
were still high. This reflected the fact that the polyphe-
nol structure with high number of hydroxyl group which 
serve to facilitate ligands in forming hydrogen bonds 
with free residue of receptor.
In addition, Fig. 1 also indicated the best receptor for 
these bioactive compounds in E. thymifolia. Following 
this chart, the line for 11β-HSD1 (1XU7) stayed at the 
upper level, followed by GFAT1 and SIRT6 at middle, 
and then the line of protein PTP1B (4Y14) located at bot-
tom of chart. This proves that the 11β-HSD1 was the best 
receptor for binding of tannin and flavonoid family. In 
term of terpenoid family, 12 compounds have 3D struc-
ture on NCBI website, and their absolute value of binding 
energy was illustrated in Fig. 1. The good binding energy 
(>|−8| kcal/mol) belonged to line of 11β-HSD1 (1XU7). 
This line has half of result which was larger 10 kcal/mol 
in term of absolute value. For this reason, the 11β-HSD1 
line located at top of chart. Followed by SIRT6 protein 
line which had 6 molecules in range of 9 and 11.5 kcal/
mol, the next position is GFAT1 line and then in the bot-
tom of chart, the PTP1B owned 10 compounds which 
had low results (<|−8|  kcal/mol). Terpenoid family had 
a highest in number of ligands in this study, but there 
were only two compounds β-amyrine and taraxerol 
were chosen for pharmacophore analysis step. Half of 
them, 6 compounds were rejected because of low result. 
Those were 2-(4-methyl-3-cyclohexene-1-yl)-2-propanol, 
limonene, phytol, piperiterone, safranal, caryophyllene 
oxide. Their absolute value of binding energy to all four 
proteins ranged from 4.7 to 6.5 kcal/mol. They all shared 
a simple structure with only one ring and few hydroxyl 
groups outside which may explain their low binding affin-
ity. Thus, these molecules appear to have a low capacity 
to form a complex with the four target proteins.
Overall, the result of this part indicated 7 com-
pounds which had high binding capacity (|binding 
energy|  >  8  kcal/mol) to all four receptors 11β-HSD1, 
PTP1B, GFAT1, SIRT6. Both tannin and terpenoid fam-
ily had 2 representers, β-amyrine and taraxerol for ter-
penoid group, corilagin and 1-O-galloyl-β-d-glucose for 
tannin family. Three last compounds belong to flavonoid 
family, cosmosiin, quercetin-3-galactoside and querci-
trin. Besides that, in three families, the line of 11β-HSD1 
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Table 1 2D structures of 20 drug candidates suggested from PubChem—NCBI
Page 5 of 13Nguyen Vo et al. SpringerPlus  (2016) 5:1359 
always stayed in highest level. It means that there is 
stronger interaction of ligand on this protein, compared 
to other three receptors. In addition, in the active site 
of PTP1B, GFAT1 and SIRT6, many compounds of E. 
thymifolia had stronger binding capacity than the con-
trols and 70 % of compounds in E. thymifolia can inter-
act with 11β-HSD1 by absolute value of binding energy 
higher 8.5 kcal/mol (Table 2). All these statistical number 
proved that, E. thymifolia is potential drug for some pro-
teins related to Type 2 DM.
Pharmacophore analysis
11β‑HSD1 and GFAT1
Pharmacophore analysis is an explanation step for 
docking result: low or high binding affinity of ligand to 
receptors. Five molecules of tannin and flavonoid group 
Table 1 continued
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(1-O-galloyl-β-d-glucose, corilagin, cosmosiin, querce-
tin-3-galactoside, quercitrin) were frequently within 
hydrogen contact with residues Ile 46, Tyr 183, Ile 121, 
Ser 170 (Fig.  2). From this observation, four residues 
seemed to be an important substrate recognition site 
of 11β-HSD1. This conclusion is strongly supported by 
studies on crystal structures and biochemical of 11β-
HSD1 (Hosfield et al. 2005; Hult et al. 2006). Especially, 
Ile 46 and Ile 121, both of them were dual role lead-
ing to close contact with five compounds by hydrogen 
bonds and also establish more hydrophobic interactions 
with benzene ring on ligand [Fig. 2(1, 2, 4)]. In addition, 
1-O-galloyl-β-d-glucoseand cosmosiin could link to the 
receptor with a high number of hydrogen bonds com-
pared to corilagin, quercetin-3-galactoside and querci-
trin. This is proper explanation for high binding affinity of 
cosmosiin. This action can be explained by the affinity of 
each steroidal hydroxyl group for the receptor. For exam-
ple, the functional group in cosmosiin could donate two 
or three hydrogen bonds with different residue such as 
Ser 43, Ser67, Arg 66, Lys 44, Gly 41, Asn 119. In tannin 
family, although 1-O-galloyl-β-d-glucose showed much 
stronger interaction than corilagin in term of hydrogen 
bond, its binding capacity was lower. To fully understand 
this phenomenon, molecular dynamic (MD) simulation 
on the complexes is suggested.
Along with hydrogen bond, hydrophobic interactions 
were also displayed. Β-amyrine and taraxerol seemed 
to be rich on hydrophobic contact at position of the 
methyl group which was non-polar [Fig.  2(6, 7)]. These 
two compounds were also in contact with this receptor 
because of the presence of the benzene ring. The residue 
Thr 124, Thr 220 and Thr 222 were three residues which 
could form not only hydrophobic interaction with terpe-
noid family but also hydrogen bond with 1-O-galloyl-β-
d-glucose, quercetin-3-galactoside, quercitrin, members 
of tannin, and flavonoid group. Furthermore, in Fig. 2(2), 
the residues Thr 220, Thr 222, Ala 223, Ile 121, Leu 217 
were frequently observed in ligand-receptor interac-
tions between, so they could be a critical part in binding 
pocket. One important thing that Ser 261 and Arg 269 




































Fig. 1 Absolute values of binding energy of 20 ligands to 4 receptors. The abbreviation of these ligands were listed as COS cosmosiin, KAE kaemp-
ferol, QUE Que, QUG quercetin-3-galactoside, QUT quercitrin, COR corilagin, GAL 1-O-galloyl-β-d-glucose1-O-galloyl-β-d-glucose, EUP euphorbol, 
2-4MET 2-(4 methyl-3-cyclohexene-1-yl)-2-propanol, 24METOL 24 methylencycloartenol, BAMY Β-amyrine, BSTI Β-sitosterol, CAM campesterol, CAR 
caryophyllene oxide, LIM limonene, PHY phytol, PIP piperiterone, SAF safranal, STI stigmasterol, TAX taraxerol. Besides that, blue line represented for 
11β-HSD1 protein, followed by the purple, green and red were labeled for PTP1B, GFAT1, SIRT6, respectively
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study involving crystal structure analysis (Hult et  al. 
2006) but in the figures from our study, these hydropho-
bic interactions were not present.
In term of GFAT1, this protein also had good binding 
energy and in some cases it had higher or equal to result 
of 11β-HSD1. Quercetin-3-galactoside, corilagin and cos-
mosiin were good illustration. Figure 3(1, 2, 3) supported 
this statement with high number of hydrogen bonds and 
hydrophobic interaction with receptor. The hydrogen 
bonds were established between GFAT and members of 
tannin and flavonoid family at position of Ser 420, Lys 
675, Gln 421, Thr 375, Ser 422 in binding pocket. This was 
also the conclusion in case of E.hirta and previous article 
of Kuo-Chen and his partners (Chou 2004). In Fig. 3, Thr 
375 and Thr 425 were especial case due to the bond they 
linked to receptor. This residue closed to not only methyl 
group but also to hydroxyl group of taraxerol and benzene 
ring of cosmosiin and quercetin-3-galactoside, quercitrin. 
Therefore, it could bind to the receptor by hydrogen and 
hydrophobic interaction. Besides that, hydrophobic was 
also displayed between Val 677, Ala 674, Thr 375 and two 
members of terpenoid family: β-amyrine and taraxerol.
SIRT6 and PTP1B
1-O-Galloyl-β-d-glucose, corilagin, cosmosiin, quercetin-
3-galactoside, quercitrin interacted with SIRT6 with the 
result of binding energy 8, 9, 9, 8.8, 9.3, 10.9, 11.5 in term 
of absolute value (Table  2). These results were smaller 
than 11β-HSD1. But there was a similarity with interac-
tion of 11β-HSD1 and ligands. All these compounds can 
form either hydrogen bond or hydrophobic interaction 
with free residue in active site of SIRT6. Tannin and fla-
vonoid family can build up hydrogen bond with Gln 111, 
Thr 213, Ser 214 [Fig. 4(1, 2, 3, 4, 5)]. Three residues that 
seem to have critical role in active site of SIRT6, but this 
output was totally difference in the studying of structure 
Table 2 Binding energy (kcal/mol) of bio-molecules in E. thymifolia to 11β-HSD1, PTP1B, GFAT and SIRT6
Family Ligand Binding energy (kcal/mol)
11β-HSD1 (1XU7) PTP1B (4Y14) GFAT (2ZJ3) SIRT6 (3K35)
Control NDP: −12.5 C0A: −8.2 AGP: −6.5 APR: −11.0
Flavonoid Sample
Cosmosiin −10.0 −7.7 −9.9 −9.0
Kaempferol −9.1 −7.4 −7.7 −8.1
Quercetin −9.7 −7.8 −7.6 −8.3
Quercetin-3-galactoside −8.9 −7.8 −9.1 −8.8
Quercitrin −9.4 −7.9 −9.0 −9.3
Tannin Corilagin −8.9 −8.4 −8.9 −9.0
1-O-Galloyl-beta-d-glucose −8.7 −6.4 −8.0 −7.9
Terpenoid Euphorbol −10.2 −7.4 −8.3 −10.4
2-(4 methyl-3-cyclohexene-1-yl)-2-propanol −6.0 −6.1 −5.4 −6.9
24 methylen cycloartenol −11.1 −7.9 −7.9 −9.0
β-Amyrine −11.6 −8.2 −9.0 −10.9
β-Sitosterol −10.3 −7.0 −7.8 −9.4
Campesterol −10.1 −6.8 −8.2 −9.4
Caryophyllene −7.8 −6.0 −7.1 −7.3
Limonene −5.5 −5.6 −4.8 −6.3
Phytol −6.0 −5.2 −5.2 −6.5
Piperiterone −5.7 −6.2 −5.4 −5.8
Safranal −5.6 −5.4 −5.5 −5.7
Stigmasterol −11.0 −7.7 −8.5 −9.7
Taraxerol −12.1 −8.4 −8.9 −11.5
(See figure on next page.) 
Fig. 2 Binding modes of selective compounds with 11β-HSD1. 1 Cosmosiin, 2 quercetin-3-galactoside, 3 quercitrin, 4 corilagin, 5 1-O-galloyl- β-d-
glucose, 6 β-amyrine, 7 taraxerol (The red and blue arrows were hydrogen donor and receptor bonds and the black round dot line was hydrophobic 
interaction. Yellow dot was hydrophobic region of ligand.)
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and biochemical function of SIRT6 of Patricia and cow-
orker (Pan et al. 2011). This can be explained by the dif-
ferent tested site in our research.
In addition, the hydrophobic interactions also played 
an important role in docking result. The good illustration 
was the difference in one methyl group at carbon number 
6 of rhamnoside ring (IUPAC name) of quercitrin com-
pared to quercetin-3-galactoside structure [Fig.  4(2, 3)]. 
This conduct to 9.3  kcal/mol binding affinity of querci-
trin compared to 8.8 kcal/mol of quercetin-3-galactoside. 
For this reason, this kind of bond between five of seven 
ligands and SIRT6 was also considerable point; these 
compounds form hydrophobic interaction with Ile 217, 
Trp186, Phe 62 at two hydrophore groups: benzene ring 
in flavonoid family and methyl group in terpenoid family 
[Fig. 4(1, 3, 6, 7)].
The docking result of PTP1B was lower compared 
to three other receptors. This can be explained by the 
number of hydrogen bond and hydrophobic interac-
tion in the link of ligands and SIRT6. For example, 
the number of hydrophobic interaction and hydrogen 
bond between taraxerol and four 11β-HSD1, SIRT6, 
GFAT1 and PTP1B were 32 [Fig. 2(7)], 23 [Fig. 3(7)], 11 
[Fig. 4(7)], 8 [Fig. 5(7)] respectively, and docking results 
were 12.1, 11.5, 8.9, 8.4 kcal/mol respectively in term of 
absolute value (Table  2). In case of corilagin, the num-
ber of hydrogen bond in PTP1B was 8 [Fig.  5(4)] com-
pared to 2 hydrogen bonds of SIRT6 [Fig.  4(4)] but the 
docking result was smaller. This action can be explained 
by the maintain time of interaction between ligand and 
receptors. The same with hydrogen bond, the number of 
hydrophobic interaction was also significantly reduced 
in arrangement from 11β-HSD1 to PTP1B. There were 
only 4 bonds between β-amyrine and PTP1B, whereas 
24 bonds in case of 11β-HSD1. The duration time of 
the interaction between ligand and receptor is high fre-
quency of residues Tyr 29, Phe 52, Ile 219 (Fig. 5) seem to 
be the significant region in active site of PTP1B.
Conclusion
In summary, from the list of 20 compounds, seven com-
pounds were chosen due to high absolute value of bind-
ing energy to all four receptors (>8  kcal/mol). They are 
β-amyrine, taraxerol, 1-O-galloyl-β-d-glucose, corilagin, 
cosmosiin, quercetin-3-galactoside and quercitrin. Poly-
phenol, the frame of tannin and flavonoid family had 
high binding affinity to all four receptors. Besides that, 
the binding affinity of two of the terpenoid compounds 
also suggested that this family is also a good prospect for 
the treatment of Type 2 DM.
Although the basic concepts of interaction between 
20 ligands of E. thymifolia and 4 receptors had been 
already defined, many questions still remained unclear 
for relationship between docking result in autodock step 
and number of bonds in 2D structure of pharmacoph-
ore analysis step. Therefore, further research is required 
using, the molecular dynamic (MD) and hydrogen bond 
analysis to clearly determined the stability of the hydro-
gen bonds and hydrophobic interactions between ligands 
and receptors.
(See figure on next page.) 
Fig. 4 Binding modes of selective compounds with SIRT6. 1 Cosmosiin, 2 quercetin-3-galactoside, 3 quercitrin, 4 corilagin, 5 1-O-galloyl-β-d-
glucose, 6 β-amyrine, 7 taraxerol. The red and blue arrows were hydrogen donor and receptor bonds and the black round dot line was hydrophobic 
interaction. Yellow dot was hydrophobic region of ligand
(See figure on previous page.) 
Fig. 3 Binding modes of selective compounds with GFAT. 1 Cosmosiin, 2 quercetin-3-galactoside, 3 quercitrin, 4 corilagin, 5 1-O-galloyl- β-d-
glucose, 6 β-amyrine, 7 taraxerol. The red and blue arrows were hydrogen donor and receptor bonds and the black round dot line was hydrophobic 
interaction. Yellow dot was hydrophobic region of ligand
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Fig. 5 Binding modes of selective compounds with PTP1B. 1 Cosmosiin, 2 quercetin-3-galactoside, 3 quercitrin, 4 corilagin, 5 1-O-galloyl-β-d-
glucose, 6 β-amyrine, 7 taraxerol. The red and blue arrows were hydrogen donor and receptor bonds and the black round dot line was hydrophobic 
interaction. Yellow dot was hydrophobic region of ligand
